Picture Name

HUAREN MEDICAL TECHNOLOGY

NEWS

01

2022-02

Guangxi Academy of Sciences follows the trend of history, leading the medical research and health care, Guangxi Huaren Medical Group leaders to assume new positions


Guangxi Academy of Sciences for further in-depth implementation of the national "" 14th Five-Year "" high-quality and efficient medical and health care service system construction implementation program "" and "" 14th Five-Year Plan for Science and Technology Innovation in Guangxi """ Science and Technology Stronger Gui three-year action plan (2021-2023) "" Guangxi Zhuang Autonomous Region People's Government on accelerating the development of major health industries and other relevant documents. -The "Guangxi Zhuang Autonomous Region People's Government on Accelerating the Development of Large Health Industry Opinions" and other relevant documents, centered on people's health, the timely formation of the "Guangxi Academy of Sciences Institute of Medicine and Health". Ji Feng, president of Guangxi Huaren Medical Group, was appointed as the first director, in order to do our best to serve our region's medical research science and technology, health, experimental animals and other industries. Carefully set up the Academy of Sciences Institute of Medicine and Health leadership team.

View More

28

2022-01

Mr. Wang Naixue, Vice Chairman of the CPPCC and other leaders visited our company.


On January 27, 2022, Wang Naixue, member of the Party Committee of Guangxi Zhuang Autonomous Region, vice chairman and member of the Party group of CPPCC of Guangxi Autonomous Region, secretary of the Party Committee of Guangxi University, and related leaders visited Guangxi Huaren Medical Science and Technology Group for investigation and research, and were warmly received by the Group's management staff, such as President Jifeng, Vice President Zeng Yong, Vice President Chen Chen, and other members of the Group, and carried out comprehensive inspections and supervisions of the enterprise construction of Huaren Group.

View More

28

2022-01

[Dry! Pubmed, do you really know how to use it?


The best database for accessing biomedical related SCI literature in China is PubMed, which deservedly tops the list and is basically the first thing that lab technologists come into contact with.If you think that PubMed is just a simple input of keywords to search for a piece of literature, then it only means that you still know very little about it!

View More

21

2022-01

Bama mini pigs a step forward in human organ transplantation


On 7 January 2022, in Baltimore, USA, a special heart transplant was carried out. A 57-year-old man with advanced heart disease received the world's first genetically modified pig heart transplant.

View More

21

2022-01

Chen Hong, Deputy Secretary of the Party Group of Nanning Municipal Government, and a group of leaders from Wuxiang New District Government came to our company for investigation.


On January 18, 2022, Chen Hong, Deputy Secretary of the Party Group of Nanning Municipal Government and Executive Deputy Director of the Administrative Committee of WuXiang New Area (Nanning Pilot Free Trade Zone), Li Ran, Deputy Secretary of the CPC Committee, Secretary of the Party Group of Nanning Municipal Government, Deputy Mayor, Acting Mayor of Nanning City Liangqing District, and the Development, Reform, Investment and Promotional Bureau of the Administrative Committee of WuXiang New Area (Nanning Pilot Free Trade Zone), the Bureau of New Economy Development, the Construction Bureau of the Administrative Committee, the government of Liangqing District, the Administrative Committee of Comprehensive Free Trade Zone, and the Five Elephants Investment Company and other relevant responsible comrades went to the Hualen Medical Joint Research & Experiment Center for research and investigation and to investigate on-site Hualen Group's development situation, technological innovation, and industry layout, and the group leaders were accompanied by them throughout the whole trip.

View More

21

2022-01

New discovery! Alzheimer's drug has efficacy in inhibiting cancer progression!


Glioblastoma multiforme is the most common primary brain cancer in adults and has a low chance of cure, almost always recurring after surgical resection, and a high level of resistance to existing treatments. However, it is possible that the immunosuppressive tumour microenvironment hides previously undiscovered therapeutic targets: it has been found that a drug used to limit the pathological accumulation of amyloid-β in the brains of Alzheimer's disease patients, MK-8931, triggers phagocytosis of the associated macrophages and kills the cancer cells, and has now been shown in a preclinical mouse model to achieving tumour control.

View More
< 1...181920...22 >